Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Interpreting Key Trials

The STAR*D study: Treating depression in the real world

Bradley N. Gaynes, MD, MPH, A. John Rush, MD, Madhukar H. Trivedi, MD, Stephen R. Wisniewski, PhD, Donald Spencer, MD, MBA and Maurizio Fava, MD
Cleveland Clinic Journal of Medicine January 2008, 75 (1) 57-66;
Bradley N. Gaynes
Associate Professor of Psychiatry, University of North Carolina School of Medicine; Investigator, Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
A. John Rush
University of Texas Southwestern Medical Center at Dallas; Professor of Clinical Sciences and Psychiatry; Principal Investigator, STAR*D study
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Madhukar H. Trivedi
University of Texas Southwestern Medical Center at Dallas; Professor of Psychiatry; National Coordinating Center, STAR*D study
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen R. Wisniewski
University of Pittsburgh School of Medicine; Associate Professor of Epidemiology; Data Coordinating Center, STAR*D study
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donald Spencer
University of North Carolina School of Medicine; Professor of Family Medicine; Investigator, STAR*D study
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maurizio Fava
Massachusetts General Hospital, Boston; Professor of Psychiatry; Investigator, STAR*D study
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

ABSTRACT

The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study evaluated feasible treatment strategies to improve clinical outcomes for real-world patients with treatment-resistant depression. Although the study found no clear-cut “winner,” it does provide guidance on how to start therapy and how to proceed if initial treatment fails.

Footnotes

  • ↵* The authors’ disclosures of potential conflicts of interest are listed at the end of this paper.

  • Copyright © 2008 The Cleveland Clinic Foundation. All Rights Reserved.
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 75 (1)
Cleveland Clinic Journal of Medicine
Vol. 75, Issue 1
1 Jan 2008
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The STAR*D study: Treating depression in the real world
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The STAR*D study: Treating depression in the real world
Bradley N. Gaynes, A. John Rush, Madhukar H. Trivedi, Stephen R. Wisniewski, Donald Spencer, Maurizio Fava
Cleveland Clinic Journal of Medicine Jan 2008, 75 (1) 57-66;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The STAR*D study: Treating depression in the real world
Bradley N. Gaynes, A. John Rush, Madhukar H. Trivedi, Stephen R. Wisniewski, Donald Spencer, Maurizio Fava
Cleveland Clinic Journal of Medicine Jan 2008, 75 (1) 57-66;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Why the irremediability requirement is not sufficient to deny psychiatric euthanasia for patients with treatment-resistant depression
  • The role of IL-6 in dopamine dysregulation underlying anhedonia phenotype in rats
  • Effect of Insomnia on Repetitive Transcranial Magnetic Stimulation Treatment Outcomes for Depression
  • Neutrophil-lymphocyte ratio across psychiatric diagnoses: An electronic health record investigation
  • Neutrophil-lymphocyte ratio across psychiatric diagnoses: a cross-sectional study using electronic health records
  • STAR*D: A Tale and Trail of Bias
  • Are all antidepressants equal?
  • Google Scholar

More in this TOC Section

  • Update in perioperative cardiac medicine 2021
  • The role of ISCHEMIA in stable ischemic heart disease
  • Renal denervation: What happened, and why?
Show more Interpreting Key Trials

Similar Articles

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire